Insulin aspart(Chongqing Chenan)

门冬胰岛素(重庆宸安)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin aspart(Chongqing Chenan)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Chenan Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Chenan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A